Wenjing Zai
Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, 200032, China
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Integrated stress response-mediated metabolic reprogramming drives hepatic stellate cell activation and liver fibrosis via the noncanonical EIF3d-ATF4-S100P signaling pathway.
Journal: Redox biology
Published: September 16, 2025
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 08, 2025
Residual viral expression in siRNA-treated HBV-replicating cell and mouse models.
Journal: Antiviral research
Published: January 27, 2025
Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy.
Journal: mBio
Published: November 21, 2024
Analysis of HBV cccDNA Minichromosome Accessibility by MNase-qPCR and High-Throughput Sequencing.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 23, 2024
Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model.
Journal: JHEP reports : innovation in hepatology
Published: May 20, 2024
Discovery of novel small molecules targeting hepatitis B virus core protein from marine natural products with HiBiT-based high-throughput screening.
Journal: Acta pharmaceutica Sinica. B
Published: April 17, 2024
Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.
Journal: Signal transduction and targeted therapy
Published: December 28, 2023
Last Updated: 09/26/2026